January 21, 2026 · Form 4 insider transaction
Tracey Kevin bought 1,220 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.; In connection with Kevin Tracey's appointment to the Board of Directors on January 21, 2026, he was awarded restricted stock units in accordance with the Non-Employee Director Compensation Program. Each award becomes fully vested on the one-year anniversary of the grant date.; Not applicable as restricted stock units do not have an expiration date.